A detailed history of Marshall Wace, LLP transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 84,174 shares of ABEO stock, worth $478,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,174
Holding current value
$478,950
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.12 - $6.32 $346,796 - $531,979
84,174 New
84,174 $531,000
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $329,861 - $703,487
81,047 Added 169.36%
128,903 $934,000
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $177,545 - $245,979
47,856 New
47,856 $239,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.